Twenty-three years of disease-free survival following cutaneous metastasis from a primary bladder transitional cell carcinoma

Int J Urol. 2004 Nov;11(11):1031-2. doi: 10.1111/j.1442-2042.2004.00939.x.

Abstract

We present a case of cutaneous metastases from a primary bladder transitional cell carcinoma (TCC), with a prolonged survival of 23 years. Cutaneous metastases from primary bladder TCC are uncommon and, like all metastases, have a poor prognosis. The common modality of treatment of cutaneous metastases from a primary bladder cancer is wide local excision of the metastases followed by combination chemotherapy. Here, we present a case of a solitary cutaneous metastasis from a primary bladder TCC, which was treated with wide local excision and single agent chemotherapy. Twenty-three years on, the patient remains disease and recurrence free.

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Carcinoma, Transitional Cell / secondary*
  • Carcinoma, Transitional Cell / therapy
  • Disease-Free Survival
  • Humans
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Skin Neoplasms / secondary*
  • Skin Neoplasms / therapy
  • Urinary Bladder Neoplasms / pathology*
  • Urinary Bladder Neoplasms / therapy

Substances

  • Antimetabolites, Antineoplastic
  • Methotrexate